Discover the optimal journal based on multiple criteria or locate authors along with their published articles and the corresponding journals.
Publisher
Subject Area
Open Acess
Quartille
Deep and sustained radiological response after MEK-RAF inhibition in HRAS mutant apocrine carcinoma of the scalp
Tackling Immunotherapy Resistance: Developing Rational Combinations of Immunotherapy and Targeted Drugs
Caso Clínico – Dor nas pernas e insuficiência renal
The rise of antibody–drug conjugates in advanced endometrial cancer
MEK inhibition for low-grade serous ovarian cancer: are we there yet?
Exploiting the folate receptor α in oncology
The evolving landscape of locally advanced cervical cancer treatment
Endocrine side effects of cancer immunotherapy
Vitamin D and cancer
Role of secondary cytoreduction in relapsed ovarian cancer
Targeting PARP1 to Enhance Anticancer Checkpoint Immunotherapy Response: Rationale and Clinical Implications
Distribution of homologous recombination deficiency (HRD) and BRCA mutations (m) detected by HRD-One test among Brazilian patients (pts) with newly diagnosed advanced epithelial ovarian, fallopian tube, or peritoneal cancer.
Emerging therapeutic targets in bladder cancer
Prevalence and clinical implications of mismatch repair (MMR) deficiency in unselected non-serous epithelial ovarian cancer (EOC) patients (pts).
CIC-DUX4 rearranged uterine cervix round-cell sarcoma exhibiting near-complete pathologic response following radiation and neoadjuvant chemotherapy: A case report
Breast and gynecologic cancers as a Brazilian health priority
Response to Paclitaxel in an Adult Patient with Advanced<b></b> Kaposiform Hemangioendothelioma
